Links

Last minute


Medtronic receives approval for new Resolute Integrity indications
Zenopa
The device has now been ratified for use in the treatment of acute coronary syndromes, acute myocardial infarction, unstable angina, bifurcations, total occlusions and in-stent restenosis, in addition to its existing indications for diabetes and ...


Ark Readies Phase 2 Study
Drug Discovery & Development
Ark Therapeutics Group plc has completed the dose ranging Phase 1 section of the academic study of Ark's VEGF-D adenoviral vector treatment for refractory angina. The study is being carried out in collaboration with the AIV Institute in Finland.
Ark Therapeutics Group plc Interim Management StatementPharmaLive.com (press release)

all 3 news articles »
 

Hot pages

angina ludwig



Bookmark us
  • Bookmark this page on Digg
  • Bookmark this page on StumbleUpon
  • Bookmark this page on del.icio.us
  • Bookmark this page on Reddit
  • Bookmark this page on Spurl
  • Bookmark this page on ThisNext